Journal of Neuroimmunology
Volume 239, Issue 1 , Pages 21-27 , 28 October 2011

Immune-mediated myelitis associated with Hepatitis virus infections

  • Joerg-Patrick Stübgen

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Neurology and Neuroscience, Weill Cornell Medical College/New York Presbyterian Hospital, 525 East 68th Street, New York, NY 10065-4885, USA. Tel.: +1 212 746 2334; fax: +1 212 746 8742.

Received 31 May 2011 ,Revised 24 July 2011 ,Accepted 2 September 2011.

References 

  1. Abramski O, Teitelbaum D. The autoimmune features of acute transverse myelopathy. Ann. Neurol. 1977;2:36–40
  2. Acharya JN, Pacheco VH. Neurologic complications of Hepatitis C. Neurologist. 2008;14:151–156
  3. Adair D, Wilkinson J, Scheck A, Radkowski M, Rakela J, Laskus T. Differential display and microarray analysis show differentially expressed genes in central nervous system in HCV infected patients and laser capture microscopy points to brain microglia as cells harboring HCV. Hepatology. 2004;40:433A
  4. Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J. Gastroenterol. Hepatol. 2009;24:1484–1493
  5. Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum. 1997;40:2007–2015
  6. Agnello V, DeRosa F. Extrahepatic disease manifestations of HCV infection: some current issues. J. Hepatol. 2004;40:341–352
  7. Aiba T, Watanabe T, Koike T, Arakawa Y. C-type hepatitis in spontaneous intracerebral hemorrhage. No To Shinkei. 1996;48:1116–1119
  8. Aktipi KM, Ravaglia S, Ceroni M, Nemni R, Debiaggi M, Bastianello S, et al. Severe recurrent myelitis in patients with hepatitis C virus infection. Neurology. 2007;68:468–469
  9. Alehan FK, Kahveci S, Uslu Y, Yildirim T, Yilmaz B. Acute disseminated encephalomyelitis associated with hepatitis A virus infection. Ann. Trop. Paediatr. 2004;24:141–144
  10. Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin. Liver Dis. 1997;1:559–568
  11. Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990;263:1218–1222
  12. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N. Engl. J. Med. 1992;327:1899–1905
  13. Alter MJ, Kruscon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Eng. J. Med. 1999;341:556–562
  14. Annunziata P, Marroni M, Francisci D, Stagni G. Acute transverse myelitis and hepatitis C virus. Infez. Med. 2005;13:45–47
  15. Authier FJ, Bassez G, Payan C, Guillevin L, Pawlotsky JM, Degos JD, et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology. 2003;60:808–812
  16. Ayabe M, Imaizumi T, Kikuchi M, Hino H, Shoji H. Clinical and immunological findings of hepatitis B virus associated spastic paraparesis — a comparison with HAM. Rinsho Shinkeigaku. 1997;37:283–286
  17. Barnaba V. Viruses, hidden self-epitopes and autoimmunity. Immunol. Rev. 1996;152:47–66
  18. Beeri R, Golan G, Newman D, Steiner I, Mevorach D, Brezis M. Transverse myelitis heralding hepatitis A. J. Clin. Gastroenterol. 1995;20:262–263
  19. Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology. 1981;31:966–971
  20. Bhat A, Naguwa S, Cheema G, Gershwin ME. The epidemiology of transverse myelitis. Autoimmun. Rev. 2010;9:A395–A399
  21. Bonetti B, Scardoni M, Monaco S, Rizzuto N, Scarpa A. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinemia. Virchows Arch. 1999;434:533–535
  22. Bonkovsky H, Mehta S. Hepatitis C: a review and update. J. Am. Acad. Dermatol. 2001;44:159–182
  23. Bosch VV, Dowling PC, Cook SD. Hepatitis A virus immunoglobulin M antibody in acute neurological disease. Ann. Neurol. 1983;14:685–687
  24. Breningstall GN, Belani KK. Acute transverse myelitis and brainstem encephalitis associated with hepatitis A infection. Paed. Neurol. 1995;12:169–171
  25. Breuer GS, Morali G, Finkelstein Y, Halevy J. A pregnant woman with hepatitis A and Guillain–Barré. J. Clin. Gastroenterol. 2001;32:179–180
  26. Brickman CM, Shoenfeld Y. The mosaic of autoimmunity. Scand. J. Clin. Lab. Invest. 2001;(Suppl. 235):3–15
  27. Bromberg K, Newhall D, Peter G. Hepatitis A and meningoencephalitis. JAMA. 1982;247:815
  28. Byrne EA, Taylor GF. An outbreak of jaundice with signs in the nervous system. Br. Med. J. 1945;1:477–478
  29. Cacciatore L, Molinari V, Manzillo G, Guadignino V, Cataldo PT, Piazza M. Letter: absence of HBsAg from cerebrospinal fluid during coma in fulminant hepatitis. Lancet. 1975;1(7904):463–464
  30. Cacoub P, Terrier B. Hepatitis B-related autoimmune manifestations. Rheum. Dis. Clin. N. Am. 2009;35:125–137
  31. Caussin-Schwemling C, Schmitt C, Stoll-Keller F. Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro. J. Med. Virol. 2001;65:14–22
  32. Centers for Disease Control and Prevention . Protection against viral hepatitis. Recommendations of the immunization practices advisory committee (ACIP). M.M.W.R. 1990;39:1–26
  33. Centers for Disease Control and Prevention . Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the immunization practices advisory committee (ACIP). M.M.W.R. 1991;1–19
  34. Chauhan A, Jameel S, Dilawari JB, Chawla YK, Kaur U, Ganguly NK. Hepatitis E virus transmission to a volunteer. Lancet. 1993;341:149–150
  35. Chitambar SD, Fadnis RS, Joshi MS, Habbu A, Bhatia SG. Case report: hepatitis A preceding Guillain–Barré syndrome. J. Med. Virol. 2006;78:1011–1014
  36. Christensen PB, Wermuth L, Hinge HH, Bomers K. Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol. Scand. 1990;81:431–435
  37. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Mans M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995;21:613–619
  38. Czaja AJ. Extrahepatic immunological features of chronic viral hepatitis. Dig. Dis. Sci. 1997;15:125–144
  39. Dankert J, Postma A, de Vries JA, Zijlstra JB. Letter: HBsAg in spinal fluid from leukemic children. Lancet. 1975;1(7908):690
  40. Davis LE, Brown JE, Robertson BH, Khanna B, Polish LB. Hepatitis A post-viral encephalitis. Acta Neurol. Scand. 1993;87:67–69
  41. Davoudi S, Soudbakhsh A, Emadikouchak H, Nikbakht G, Modabbernia A. Meningoencephalitis associated with hepatitis A infection: a case report and review of the literature. Trop. Doct. 2010;40:176–177
  42. De Carli DM, Pannebeker J, Pedro FL, Haygert CJ, Hertz E, Beck Mde O. Transverse myelitis associated with HCV infection. Braz. J. Infect. Dis. 2009;13:147–152
  43. De Seze J, Stojkovic T, Breteau G, Lucas C, Michon-Pasturel U, Gauvrit JY, et al. Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases. Brain. 2001;124:1509–1521
  44. De Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewski S, et al. Idiopathic acute transverse myelitis: application of recent diagnostic criteria. Neurology. 2005;65:1950–1953
  45. Dienstag JL, Szmuness W, Stevens CE, Purcell RH. Hepatitis A virus infection: new insights from seroepidemiologic studies. J. Infect. Dis. 1978;137:328–340
  46. Earnest BS, Men LC, Sukvinder Kaur G, Alias RB, Sunita Devi H. Chronic hepatitis C infection associated with neuromyelitis optica and antinuclear antibodies. J. Assoc. Physicians India. 2010;58:118–120
  47. Ferri C, Zignego A. Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr. Opin. Rheumatol. 2000;12:53–60
  48. Feutren G, Gerbal JL, Allinquant B, Schuller E. Association of Guillain–Barré syndrome and B-virus hepatitis: simultaneous presence of anti-ds-DNA antibodies and HBs antigen in cerebrospinal fluid. J. Clin. Lab. Immunol. 1983;11:161–164
  49. Ficko C, Imbert P, Mechaî F, Barruet R, Nicand E, Rapp C. Acute myelitis related to hepatitis A after travel to Senegal. Med. Trop. (Mars.). 2010;70:7–8
  50. Filippini D, Colombo F, Jann S, Cornero R, Canesi B. Central nervous system involvement in patients with HCV-related cryoglobulinemia: literature review and case report. Reumatismo. 2002;54:150–155
  51. Francis DP, Favero MS, Maynard JE. Transmission of hepatitis B virus. Semin. Liver Dis. 1981;1:27–32
  52. Frohman EM, Wingerchuk DM. Transverse myelitis. N. Engl. J. Med. 2010;263:564–572
  53. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin. Microbiol. Rev. 2006;9:80–94
  54. Gerber M, Thung SN. Molecular and cellular pathology of hepatitis B. Lab. Invest. 1985;52:572–590
  55. Glikson M, Galun E, Orun R, Tur-Kaspa R, Shouval D. Relapsing hepatitis A. A review of 14 cases and literature review. Medicine (Baltimore). 1992;71:14–23
  56. Grewal AK, Lopes MB, Berg CL, Bennett AK, Alves VA, Trugman JM. Recurrent demyelinating myelitis associated with hepatitis C viral infection. J. Neurol. Sci. 2004;224:101–106
  57. Guignard D, Nydegger U, Lambert PH, Miescher PA. Physiopathology of hepatitis B virus infection. Schweiz. Med. Wochenschr. 1975;16:1033–1040
  58. Hammond GW, Macdougal BK, Plummer F, Sekla LH. Encephalitis during the prodromal stage of acute hepatitis A. Can. Med. Assoc. J. 1982;126:269–270
  59. Hansen KE, Arnason J, Bridges AJ. Autoantibodies and common viral illnesses. Semin. Arthritis Rheum. 1998;27:263–271
  60. He XY, Fang LJ, Zhang YE, Sheng FY, Zhang XR, Guo MY. In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr. Nephrol. 1998;12:117–120
  61. Hickey WF. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 1999;11:125–137
  62. Hino H, Ayabe M, Honda J, Shoji H, Oizumi K. Hepatitis B virus antibody positive spastic paraparesis. Clin. Neurol. 1994;34:691–695
  63. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology. 1997;26:15S–20S(Supplement)
  64. Huet PM, Layrargues GP, Lebrun LH, Richer G. Hepatitis B surface antigen in the cerebrospinal fluid in a case of Guillain–Barré syndrome. Can. Med. Assoc. J. 1980;122:1157–1159
  65. Igarashi M, Tomono M, Uchida S, Yamashiro Y, Namihisa T, Tanaka S. Guillain–Barré syndrome associated with acute hepatitis A. Gastroenterol. Jpn. 1983;18:549–552
  66. Inman RD, Hodge M, Johnston ME, Heathcote J. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann. Intern. Med. 1986;105:700–703
  67. Inoue K, Yoshiba M, Yotsuyanagi R, Otsuka T, Sekiyama K, Fujita R. Chronic hepatitis A with persistent viral replication. J. Med. Virol. 1996;50:322–324
  68. Inoue J, Ueno Y, Kogure T, Nagasaki F, Kimura O, Obara N, et al. Analysis of the full-length genome of hepatitis B virus in the serum and cerebrospinal fluid of a patient with acute hepatitis B and transverse myelitis. J. Clin. Virol. 2008;41:301–304
  69. Jacob A, Weinshenker BG. An approach to the diagnosis of acute transverse myelitis. Semin. Neurol. 2008;28:105–120
  70. Jean G, Gaussorgues P, Robert D. Hepatitis B virus replication in the cerebrospinal fluid in Guillain–Barré syndrome. Presse Med. 1991;20:428–429
  71. Jeffrey DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch. Neurol. 1993;50:532–535
  72. Jouhadi Z, Ouazzani I, Abid A, El Moutawaki B, Rafai MA, Slassi I. Devic's optic neuromyelitis and viral hepatitis type A. A paediatric case report. Rev. Neurol. (Paris). 2004;160:1198–1202
  73. Kanda T. Chronic hepatitis C infection and peripheral neuropathy; is mixed cryoglobulinemia really important?. Intern Med. 2003;42:377–378
  74. Kansu A, Kuloglu Z, Demiceken F, Girgin N. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha. Turk. J. Gastroenterol. 2004;15:213–218
  75. Khemiri M, Ouederni S, Barsaoui S. A new case of acute transverse myelitis following hepatitis A virus infection. Med. Mal. Infect. 2007;37:237–239
  76. Kim SY, Kim MG, Choi WC. Acute transverse myelitis after acute hepatitis A: findings on magnetic resonance imaging. Clin. Gastroenterol. Hepatol. 2008;6:xxviii-e1.
  77. Kincaid O, Lipton HL. Viral myelitis: an update. Curr. Neurol. Neurosci. Rep. 2006;6:469–474
  78. Kocabas E, Yildizdas D. A child with Guillain–Barré syndrome caused by acute hepatitis A infection. Indian Pediatr. 2004;41:92–93
  79. Kotzin BL, Leung J, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv. Immunol. 1993;54:99–166
  80. Laskus T, Radkowski M, Bednarska A, Wilkinson J, Adair D, Nowicki M, et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J. Virol. 2002;76:10064–10068
  81. Laskus T, Radkowski M, Adair DM, Wilkinson J, Scheck AC, Rakela J. Emerging evidence of hepatitis C virus neuroinvasion. AIDS. 2005;19(Supplement 3):S140–S144
  82. Lauer GM, Walker GM. Hepatitis C virus infection. N. Engl. J. Med. 2001;345:41–52
  83. Lavi E, Suzumura A, Murray EM, Silberberg DH, Weiss SR. Induction of MHC class I antigens on glial cells is dependent on persistent mouse hepatitis virus infection. J. Neuroimmunol. 1989;22:107–111
  84. Lee WM. Hepatitis B virus infection. N. Engl. J. Med. 1997;337:1733–1745
  85. Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC. Association between hepatitis B virus and essential mixed cryoglobulinemia. N. Engl. J. Med. 1977;296:1501–1504
  86. Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49:S13–S21(Supplement)
  87. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 2000;132:296–305
  88. Lidove O, Maisonobe T, Servan J, Thibault V, Léger JM, Piette JC, et al. Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia. Rev. Med. Interne. 2001;22:939–947
  89. Lipton HL, Teasdall RD. Acute transverse myelopathy in adults. Arch. Neurol. 1973;28:252–257
  90. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2001;34:1225–1241
  91. Maîga MY, Oberti F, Calés P. Extrahepatic manifestations of hepatitis A virus infection. Gastroenterol. Clin. Biol. 1996;20:346–352
  92. Mandal K, Chopra N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr. 2006;43:365–366
  93. Mason A. Role of viral replication in extrahepatic syndromes related to hepatitis B virus infection. Minerva Gastroenterol. Dietol. 2006;52:53–66
  94. Mason A, Theal J, Bain V, Adams E, Perrillo R. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease. Am. J. Gastroenterol. 2005;100:972–976
  95. Matsui M, Kakigi R, Watanabe S, Kuroda Y. Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier. J. Neurol. Sci. 1996;139:235–237
  96. Matsushima K, Niwa K, Fujita H, Yamamoto M, Shinohara Y. Acute hepatitis A (HA) presenting findings of meningoencephalitis. Rinsho Shinkeigaku. 1992;32:441–443
  97. Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clinic. Rev. Allerg. Immunol. 2008;34:85–102
  98. Mayo MJ. Extrahepatic manifestations of hepatitis C infection. Am. J. Med. Sci. 2003;325:135–148
  99. McCoy L, Tsunoda I, Fujinami RS. Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity. 2006;39:9–19
  100. McDonald GS, Courtney MG, Shattock AG, Weir DG. Prolonged IgM antibodies and histopathological evidence off chronicity in hepatitis A. Liver. 1989;9:223–238
  101. McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J. Infect. Dis. 1985;151:599–603
  102. Miller RH, Robinson WS. Common evolutionary origin of hepatitis B virus and retroviruses. Proc. Natl. Acad. Sci. U. S. A. 1986;83:2531–2535
  103. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch KL, Neville Y, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997;3:1133–1136
  104. Mouelhi L, Mekki H, Houissa F, Debbeche R, Ben Rejeb M, Bouzaidi S, et al. Transverse myelitis associated with chronic viral hepatitis C. Tunis Med. 2010;88:116–118
  105. Nahill SR, Welsh RM. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 1993;177:710–715
  106. Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinemia. J. Neurol. Neurosurg. Psychiatry. 2003;74:1267–1271
  107. Nishimura M, Shigemoto R, Matsubayashi K, Mimori Y, Kameyama M. Meningoencephalitis during the pre-icteric phase of hepatitis A — a case report. Rinsho Shinkeigaku. 1987;27:1441–1444
  108. Nishioka K. Epidemiological studies on hepatitis C virus infection: detection, prevalence, exposure and prevention. Intervirology. 1994;37:58–67
  109. Nolte CH, Endres AS, Meisel H. Sensory ataxia in myelopathy with chronic hepatitis C virus infection. Neurology. 2002;59:958
  110. Nothdurft HD. Hepatitis A vaccines. Expert Rev. Vaccines. 2008;7:535–545
  111. Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol. 2001;14:227–250
  112. Pacheco VH, Acharya JN. Recurrent myelopathy and hepatitis C infection. Ann. Neurol. 2006;60(Supplement 3):S45
  113. Parajuå JL, Riera M, Garcîa MJ. Hepatitis A encephalitis. Med. Clin. (Barc.). 1991;97:279
  114. Pelletier G, Elghozi D, Trepo C, Laverdant C, Benhamou JP. Mononeuritis in acute viral hepatitis. Digestion. 1985;32:53–56
  115. Penner E, Maida E, Mamoli B, Gangl A. Serum and cerebrospinal fluid immune complexes containing hepatitis B surface antigen in Guillain–Barré syndrome. Gastroenterology. 1982;82:576–580
  116. Petty GW, Duffy J, Houston J. Cerebral ischemia in patients with hepatitis C virus infection and cryoglobulinemia. Mayo Clin. Proc. 1996;71:671–678
  117. Pines E, Pines A. Aseptic meningitis: a rare prodromal manifestation of infectious hepatitis. Harefuah. 1982;102:110–111
  118. Pischke S, Potthoff A, Hauroder B, Schlué J, Manns MP, Cornberg M, et al. Hepatitis E virus infection: a paradigm shift?. Dtsch. Med. Wochenschr. 2010;135:1129–1133
  119. Porst H, Hentschel R, Sauermann W, Lehmann HU, Lohmann J, Schentke KU. Guillain–Barré polyradiculitis in acute viral hepatitis type B: case report. Dtsch. Z. Verdau. Stoffwechselkr. 1983;43:146–149
  120. Probst T, Probst A, Nachbauer K, Graziadei I, Willeit H, Margreiter R, et al. Papillitis and vasculitis of the arteria spinalis anterior as complication of hepatitis C reinfection after liver transplantation. Transpl. Int. 1997;10:234–237
  121. Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J. Virol. 2002;76:600–608
  122. Ramos-Casals M, Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr. Opin. Rheumatol. 2005;17:447–455
  123. Rao UB, Suri ML, Gupta S. Infectious hepatitis with myelitis and neuritis. J. Indian Med. Assoc. 1968;51:460–463
  124. Ropper AH, Poskanzer DC. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Neurology. 1978;4:51–59
  125. Sansonno D, Iacobelli AR, Cornacchiulo V, Iodice G, Damacco F. Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotope in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients. Clin. Exp. Immunol. 1996;103:414–421
  126. Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine. 1992;10:S18–S20
  127. Schiliro G, Russo A, Marino S, Musumeci S. HBsAg in spinal fluid in leukemia. Lancet. 1975;2(7939):816–817
  128. Seeger C, Ganem D, Varmus HE. Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science. 1986;232:477–484
  129. Selves J, Kamar N, Mansuy JM, Péron JM. Hepatitis E virus: a new entity. Ann. Pathol. 2010;30:432–438
  130. Séne D, Limal N, Cacoub P. Hepatitis C virus-associated extrahepatic manifestations: a review. Metab. Brain Dis. 2004;19:357–381
  131. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case control study. Ann. Intern. Med. 1992;116:97–102
  132. Sobukawa E, Sakimura K, Hoshino S, Hoshino M, Miyoshi K. Hepatic myelopathy: an unusual neurological complication of advanced liver disease. Int. Med. 1994;33:718–722
  133. Spiegel RJ, Tabor E, Pizzo PA, Gerety RJ. Hepatitis B surface antigen in spinal fluid. Med. Pediatr. Oncol. 1980;8:115–121
  134. Tabor E. Guillain–Barré syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B. J. Med. Virol. 1987;21:207–216
  135. Takahashi-Fujigasaki J, Takagi S, Sakamoto T, Inoue K. Spinal cord biopsy findings of anti-aquaporin-4 antibody-negative recurrent longitudinal myelitis in a patient with sicca and hepatitis C viral infection. Neuropathology. 2009;29:472–479
  136. Teshale EH, Hu DJ, Holmberg SD. The two faces of hepatitis E virus. Clin. Infect. Dis. 2010;51:328–334
  137. Thapa R, Biswas B, Mallick D, Mukherjee S. Pharyngeal–cervical–brachial variant of pediatric Guillain–Barré syndrome with antecedent acute hepatitis A infection. J. Child Neurol. 2009;24:865–867
  138. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature. 1985;317:489–495
  139. Transverse Myelitis Consortium Working Group . Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59:499–505
  140. Trepo C, Bolot JF, Robert D, Sepetjian M, Prince AM. Letter: absence of HBsAg and anti-HBs in spinal fluid. Lancet. 1974;2(7895):1514
  141. Tsukada N, Koh CS, Inoue A, Yanagisawa N. Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen. J. Neurol. Sci. 1987;77:203–216
  142. Tyler KL, Gross RA, Cascino GD. Unusual viral causes of transverse myelitis: hepatitis A virus and cytomegalovirus. Neurology. 1986;36:855–858
  143. Valentini G, Mantelli A, Persico M, Tuccillo C, Del Veccho Blanco G, Morisco F, et al. Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions. Clin. Exp. Rheumatol. 1999;17:75–79
  144. Vishwanathan R. Infectious hepatitis in Delhi (1955–1956): a critical study: epidemiology. Indian J. Med. Res. 1957;45(Supplement 1):1–29
  145. Wasley A, Fiore A, Bell BP. Hepatitis A in era of vaccination. Epidemiol. Rev. 2006;28:101–111
  146. Wilson RA. Extrahepatic manifestations of chronic viral hepatitis. Am. J. Gastroenterol. 1997;92:3–17
  147. Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J. Clin. Invest. 2001;108:1097–1104
  148. Yoffe B, Burns DK, Bhate HS, Combes B. Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. Hepatology. 1990;12:187–192
  149. Zandman-Goddard G, Levy Y, Weiss P, Shoenfeld Y, Langevitz P. Transverse myelitis associated with chronic hepatitis C. Clin. Exp. Rheumatol. 2003;21:111–113

PII: S0165-5728(11)00254-2

doi: 10.1016/j.jneuroim.2011.09.001

Journal of Neuroimmunology
Volume 239, Issue 1 , Pages 21-27 , 28 October 2011

Article Tools